A Safety and Effectiveness Prospective Blinded Clinical Study to Validate xBar System as Monitoring Tool for Anastomotic Leaks Detection
1 other identifier
interventional
190
2 countries
13
Brief Summary
Purpose: To validate the safety and effectiveness of xBar monitoring tool for detection of post-operative anastomotic leaks in subjects undergoing rectal/sigmoid resections with anastomosis. The clinical team is blinded to the leak detection of the xBar system.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2023
Typical duration for not_applicable
13 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 11, 2023
CompletedFirst Submitted
Initial submission to the registry
December 4, 2023
CompletedFirst Posted
Study publicly available on registry
December 13, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2025
CompletedSeptember 30, 2025
September 1, 2025
2.7 years
December 4, 2023
September 29, 2025
Conditions
Outcome Measures
Primary Outcomes (4)
Safety
Lack of unanticipated serious adverse events related to the xBar system or xBar procedure during the study period.
through study completion, an average of 1 year
Safety - Severe leak rate - comparable to SOC.
Statistical evaluation of prevalence of anastomotic leaks in the study group compared to the prevalence present in the literature.
through study completion, an average of 1 year
Performance - successful xBar placement.
The device is working properly and records data in 90% of the cases or more.
through study completion, an average of 1 year
Performance - Sensitivity and Specificity of severe leak detection
Sensitivity and Specificity are non-inferior compared to Standard of care at POD 3
through study completion, an average of 1 year
Study Arms (1)
Singel arm
OTHERAll patients will be treated with the investigational device.
Interventions
xBar system is surgical drain with embedded sensors. Collected data will be evaluated for an ability to identify anastomotic leaks. The xBar system does not have therapeutic indication.
Eligibility Criteria
You may qualify if:
- Age ≥ 22 years
- Indication for sigmoid or rectal resection surgery.
- Usage of drain during the surgery (to be confirmed during the surgery)
- Willing and able to comply with the study follow up.
- Able and agree to provide an informed consent.
You may not qualify if:
- Contraindication for surgery and/or general anesthesia.
- Pregnancy or lactation.
- Planned or unplanned fecal diversion during the surgery (to be confirmed during the surgery)
- Known electronic device implanted in the chest or the abdominal cavity (e.g., pacemaker, cardioverter/defibrillator).
- Major medical or psychiatric illness or condition, or other factors that may affect general health or ability to adhere to the follow-up schedule.
- Known allergic reactions to materials used in the components of the xBar system, i.e., silicone, rubber and stainless-steel.
- Participation in another interventional study during the xBar system usage.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (13)
AdventHealth Orlando
Orlando, Florida, 328803, United States
AdventHealth Tampa
Tampa, Florida, 33613, United States
University of Louisville
Louisville, Kentucky, 40202, United States
Henry Ford Health
Detroit, Michigan, 48202, United States
Bryan Medical Center
Lincoln, Nebraska, 68506, United States
Weill Cornell MC, NY
New York, New York, 10021, United States
Mount Sinai Health System
New York, New York, 10029, United States
Northwell Health, NY
New York, New York, 10075, United States
Stony Brook University Hospital and Cancer Center
New York, New York, 11794-8191, United States
HCA
Houston, Texas, 77030, United States
Soroka MC
Beersheba, Israel
Rabin MC
Petah Tikva, Israel
Kaplan MC
Rehovot, Israel
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Masking Details
- Investigators, clinical teams and subjects will be blinded to the outcomes provided by xBar system. Post operative monitoring will be as per SOC.
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 4, 2023
First Posted
December 13, 2023
Study Start
March 11, 2023
Primary Completion
December 1, 2025
Study Completion
December 1, 2025
Last Updated
September 30, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will not share